These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 14758760)

  • 1. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
    Patel RN
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo-enzymatic synthesis of pharmaceutical intermediates.
    Patel RN
    Expert Opin Drug Discov; 2008 Feb; 3(2):187-245. PubMed ID: 23480222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalysis for synthesis of pharmaceuticals.
    Patel RN
    Bioorg Med Chem; 2018 Apr; 26(7):1252-1274. PubMed ID: 28648492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances.
    Patel RN
    Curr Opin Biotechnol; 2001 Dec; 12(6):587-604. PubMed ID: 11849941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in biocatalytic synthesis of pharmaceutical intermediates.
    Panke S; Wubbolts M
    Curr Opin Chem Biol; 2005 Apr; 9(2):188-94. PubMed ID: 15811804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic synthesis of chiral intermediates for pharmaceuticals.
    Patel R; Hanson R; Goswami A; Nanduri V; Banerjee A; Donovan MJ; Goldberg S; Johnston R; Brzozowski D; Tully T; Howell J; Cazzulino D; Ko R
    J Ind Microbiol Biotechnol; 2003 May; 30(5):252-9. PubMed ID: 12687489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric biocatalysis with microbial enzymes and cells.
    Wohlgemuth R
    Curr Opin Microbiol; 2010 Jun; 13(3):283-92. PubMed ID: 20434391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in industrial biocatalysis.
    Nestl BM; Nebel BA; Hauer B
    Curr Opin Chem Biol; 2011 Apr; 15(2):187-93. PubMed ID: 21195018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocatalytic synthesis of chiral alcohols and amino acids for development of pharmaceuticals.
    Patel RN
    Biomolecules; 2013 Oct; 3(4):741-77. PubMed ID: 24970190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalable enantioselective processes for chiral pharmaceutical intermediates.
    Iida T; Mase T
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in enzymatic resolution and desymmetrization of pharmaceuticals and their intermediates.
    Pesti JA; DiCosimo R
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):884-901. PubMed ID: 14758759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and utilization of biocatalysts for chiral synthesis: an overview of Chinese scientists' research and development.
    Yu HL; Xu JH; Lu WY; Lin GQ
    Adv Biochem Eng Biotechnol; 2009; 113():1-31. PubMed ID: 19623477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologically active compounds in the environment and their chirality.
    Kasprzyk-Hordern B
    Chem Soc Rev; 2010 Nov; 39(11):4466-503. PubMed ID: 20852776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of drugs by microbial biosynthesis and biotransformation. Possibilities, limits and future developments (1st communication).
    Kieslich K
    Arzneimittelforschung; 1986 Apr; 36(4):774-8. PubMed ID: 3718602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity in drug metabolism.
    Lu H
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial transformation of azaarenes and potential uses in pharmaceutical synthesis.
    Parshikov IA; Netrusov AI; Sutherland JB
    Appl Microbiol Biotechnol; 2012 Aug; 95(4):871-89. PubMed ID: 22740048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of saturated nitrogen-containing heterocyclic compounds by microorganisms.
    Parshikov IA; Silva EO; Furtado NA
    Appl Microbiol Biotechnol; 2014 Feb; 98(4):1497-506. PubMed ID: 24352731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.